Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases

Journal of Rheumatology

Volumn 27, Issue 5, 2000, Pages 1265-1270

  Sanden, Stefanie ^a   Tripmacher, Robert ^a   Weltrich, Renita ^a   Rohde, Wolfgang ^a   Hiepe, Falk ^a   Burmester, Gerd Rüdiger ^a   Buttgereit, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Downregulation; Glucocorticoid receptor; Glucocorticoid therapy; Nongenomic effects

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PREDNISOLONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DOSE RESPONSE; HUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RHEUMATIC DISEASE; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PREDNISOLONE; RECEPTORS, GLUCOCORTICOID; RHEUMATIC DISEASES;

EID: 0034021412     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Buttgereit F, Wehling M, Burmester GR. A new hypothesis of modular glucocorticoid actions. Glucocorticoid treatment of rheumatic diseases revisited. Arthritis Rheum 1998;41:761-7.
2. Tanaka H, Akama H, Ichikawa Y, Makino I, Homma M. Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J Rheumatol 1992;19:878-83.
3. Tan EM, Cohen AA, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1992;25:1271-7.
4. Zonana-Nacach A, Salas M, Sanchez ML, Camargo-Coronel A, Bravo-Gatica C, Mintz G. Measurements of clinical activity of systemic lupus erythematosus and laboratory abnormalities: a 12-month prospective study. J Rheumatol 1995;22:45-9.
5. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
6. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
7. Scatchard G. The attractions of proteins by small molecules and ions. Ann NY Acad Sci 1949;51:660-72.
8. Tanaka H, Akama H, Ichikawa Y, Homma M, Oshima H. Glucocorticoid receptors in normal leukocytes: effects of age, gender, season, and plasma cortisol concentrations. Clin Chem 1991;37:1715-9.
9. Spahn JD, Szefler SJ, Surs W, Doherty DE, Nimmagadda SR, Leung DY. A novel action of IL-13: induction of diminished monocyte glucocorticoid receptor-binding affinity. J Immunol 1996;157:2654-9.
10. Kam JC, Szefler SJ, Surs W, Sher ER, Leung DY. Combination IL-2 and 1L-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids. J Immunol 1993;151:3460-6.
11. Shimada T, Hiwatashi N, Yamazaki H, Kinouchi Y, Toyota T. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis. Dis Colon Rectum 1997;40:S54-8.
12. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum 1992;35:740-4.
13. Molijn GJ, Koper JW, van Uffelen CJ, et al. Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol Oxf 1995;43:197-203.
14. Sher ER, Leung DY, Surs W, et al. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994;93:33-9.
15. Armanini D. Corticosteroid receptors in lymphocytes: a possible marker of brain involution? J Steroid Biochem Mol Biol 1994;49:429-34.
16. Sartori ML, Masera RG, Staurenghi A, Racca S, Angeli A. Interleukin 2 up-regulates glucocorticoid receptor number in human peripheral blood mononuclear cells and the osteosarcoma cell line Saos-2 in vitro. Steroids 1998;63:349-51.
17. + into concanavalin A-stimulated thymocytes. Biochem J 1997;326:329-32.
18. Buttgereit F, Grant A, Müller M, Brand MD. The effects of methylprednisolone on oxidative phosphorylation in concanavalin A-stimulated thymocytes: top-down elasticity analysis and control analysis. Eur J Biochem 1994;223:513-9.
19. Buttgereit F, Brand MD, Burmester GR. Equivalent doses and relative drug potencies for nongenomic glucocorticoid effects. Biochem Pharm 1999;58:363-8.
20. Burnstein KL, Jewell CM, Cidlowski JA. Human glucocorticoid receptor cDNA contains sequences sufficient for receptor down-regulation. J Biol Chem 1990;265:7284-91.
21. Shipman GF, Bloomfield CD, Gajl-Peczalska KJ, Munck AU, Smith KA. Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood 1983;61:1086-90.
22. Schlechte JA, Ginsberg BH, Sherman BM. Regulation of the glucocorticoid receptor in human lymphocytes. J Steroid Biochem 1982;16:69-74.
23. Burnstein KL, Cidlowski JA. The down side of glucocorticoid receptor regulation. Mol Cell Endocrinol 1992;83:C1-8.
24. Silva CM, Powell-Oliver FE, Jewell CM, Sar M, Allgood VE, Cidlowski JA. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994;59:436-42.
25. Brönnegård M. Steroid receptor number. Individual variation and downregulation by treatment. Am J Resp Crit Care Med 1996;154:S28-32.
26. Barrett TJ, Vig E, Vedeckis WV. Coordinate regulation of glucocorticoid receptor and c-jun gene expression is cell type-specific and exhibits differential hormonal sensitivity for down-and up-regulation. Biochemistry 1996;35:9746-53.
27. Burnstein KL, Bellingham DL, Jewell CM, Powell-Oliver FE, Cidlowski JA. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991;56:52-8.
28. Knutsson PU, Brönnegård M, Marcus C, Stierna P. Regulation of glucocorticoid receptor mRNA in nasal mucosa by local administration of fluticasone and budesonide. J Allergy Clin Immunol 1996;97:655-61.
29. Vachier I, Roux S, Chanez P, et al. Glucocorticoids induced down-regulation of glucocorticoid receptor mRNA expression in asthma. Clin Exp Immunol 1996;103:311-5.
30. Bamberger CM, Schulte HM, Chrousos GP. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev 1996;17:245-61.
31. Kumar MV, Tindall DJ. Transcriptional regulation of the steroid receptor genes. Prog Nucl Acid Res Mol Biol 1998;59:289-306.
32. Hoeck W, Rusconi S, Groner B. Down-regulation and phosphorylation of glucocorticoid receptors in cultured cells. J Biol Chem 1989;264:14396-402.
33. Dong Y, Poellinger L, Gustafsson JA, Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 1988;2:1256-64.
34. McIntyre WR, Samuels HH. Triamcinolone acetonide regulates glucocorticoid-receptor levels by decreasing the half-life of the activated nuclear-receptor form. J Biol Chem 1985;260:418-27.
35. Cidlowski JA, Cidlowski NB. Regulation of glucocorticoid receptors by glucocorticoids in cultured HeLa S3 cells. Endocrinology 1981;109:1975-83.
36. Gladman DD, Urowitz MB, Doris F, Lewandowski K, Anhorn K. Glucocorticoid receptors in systemic lupus erythematosus. J Rheumatol 1991;18:681-4.
37. Rupprecht M, Rupprecht R, Kornhuber J, et al. Elevated glucocorticoid receptor concentrations before and after glucocorticoid therapy in peripheral mononuclear leukocytes of patients with atopic dermatitis. Dermatologica 1991;183:100-5.